Soria-Chacartegui, P.; Zubiaur, P.; Ochoa, D.; Villapalos-GarcÃa, G.; Román, M.; Matas, M.; Figueiredo-Tor, L.; MejÃa-Abril, G.; Calleja, S.; de Miguel, A.;
et al. Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 2023, 15, 404.
https://doi.org/10.3390/pharmaceutics15020404
AMA Style
Soria-Chacartegui P, Zubiaur P, Ochoa D, Villapalos-GarcÃa G, Román M, Matas M, Figueiredo-Tor L, MejÃa-Abril G, Calleja S, de Miguel A,
et al. Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics. 2023; 15(2):404.
https://doi.org/10.3390/pharmaceutics15020404
Chicago/Turabian Style
Soria-Chacartegui, Paula, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-GarcÃa, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina MejÃa-Abril, SofÃa Calleja, Alejandro de Miguel,
and et al. 2023. "Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety" Pharmaceutics 15, no. 2: 404.
https://doi.org/10.3390/pharmaceutics15020404
APA Style
Soria-Chacartegui, P., Zubiaur, P., Ochoa, D., Villapalos-GarcÃa, G., Román, M., Matas, M., Figueiredo-Tor, L., MejÃa-Abril, G., Calleja, S., de Miguel, A., Navares-Gómez, M., MartÃn-Vilchez, S., & Abad-Santos, F.
(2023). Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics, 15(2), 404.
https://doi.org/10.3390/pharmaceutics15020404